Gopal Krishna

4.5k total citations
65 papers, 3.0k citations indexed

About

Gopal Krishna is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Gopal Krishna has authored 65 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 29 papers in Epidemiology and 21 papers in Pharmacology. Recurrent topics in Gopal Krishna's work include Antifungal resistance and susceptibility (29 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Pharmaceutical studies and practices (11 papers). Gopal Krishna is often cited by papers focused on Antifungal resistance and susceptibility (29 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Pharmaceutical studies and practices (11 papers). Gopal Krishna collaborates with scholars based in United States, Germany and United Kingdom. Gopal Krishna's co-authors include Monika Martinho, Allen Moton, Angela Sansone‐Parsons, Bhavna Kantesaria, Lei Ma, James F. McLeod, Lei Ma, Edward O’Mara, Matthew M. Medlock and David Wexler and has published in prestigious journals such as Neurology, Antimicrobial Agents and Chemotherapy and Pharmaceutical Research.

In The Last Decade

Gopal Krishna

61 papers receiving 2.9k citations

Peers

Countries citing papers authored by Gopal Krishna

Since Specialization

Citations

This map shows the geographic impact of Gopal Krishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gopal Krishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gopal Krishna more than expected).

Fields of papers citing papers by Gopal Krishna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gopal Krishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gopal Krishna. The network helps show where Gopal Krishna may publish in the future.

Co-authorship network of co-authors of Gopal Krishna

This figure shows the co-authorship network connecting the top 25 collaborators of Gopal Krishna. A scholar is included among the top collaborators of Gopal Krishna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gopal Krishna. Gopal Krishna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults 2023 ·Cancer Chemotherapy and Pharmacology ·Yizhe Chen, D.J. Wyatt, Massimo Attanasio, Mark Thomas, Michael A. Thomas, Bing He, Rina Nishii, Liangang Liu, (unknown), Yongjun Xue, Leonidas N. Carayannopoulos, K. OGASAWARA, Gopal Krishna	2
2	Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participants 2021 ·Cancer Chemotherapy and Pharmacology ·K. OGASAWARA, (unknown), Mark Thomas, Liangang Liu, (unknown), Yongjun Xue, Sekhar Surapaneni, Leonidas N. Carayannopoulos, Simon Zhou, Maria Palmisano, Gopal Krishna	8
3	Impact of fedratinib on the pharmacokinetics of transporter probe substrates using a cocktail approach 2021 ·Cancer Chemotherapy and Pharmacology ·K. OGASAWARA, (unknown), Mark Thomas, Michael A. Thomas, Liangang Liu, (unknown), Yongjun Xue, Sekhar Surapaneni, Leonidas N. Carayannopoulos, Simon Zhou, Maria Palmisano, Gopal Krishna	13
4	Excretion balance and pharmacokinetics following a single oral dose of [14C]-fedratinib in healthy subjects 2020 ·Cancer Chemotherapy and Pharmacology ·K. OGASAWARA, Christine Xu, (unknown), (unknown), Sekhar Surapaneni, (unknown), Maria Palmisano, Gopal Krishna	11
5	Effects of repeated oral doses of ketoconazole on a sequential ascending single oral dose of fedratinib in healthy subjects 2020 ·Cancer Chemotherapy and Pharmacology ·K. OGASAWARA, Christine Xu, (unknown), Maria Palmisano, Gopal Krishna	16
6	A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjects 2020 ·Cancer Chemotherapy and Pharmacology ·K. OGASAWARA, Bradley Vince, Christine Xu, Meng Zhang, Maria Palmisano, Gopal Krishna	8
7	Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib 2020 ·Cancer Chemotherapy and Pharmacology ·Fan Wu, Gopal Krishna, Sekhar Surapaneni	16
8	Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia 2019 ·Cancer Chemotherapy and Pharmacology ·K. OGASAWARA, Simon Zhou, Gopal Krishna, Maria Palmisano, Yan Li	25
9	Gastroprotective effect of flower extracts of Hibiscus rosa sinensis against acute gastric lesion models in rodents 2014 ·Journal of Pharmacognosy and Phytochemistry ·(unknown), Akula Annapurna, (unknown), (unknown), Gopal Krishna, (unknown)	10
10	Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers 2011 ·Expert Opinion on Drug Metabolism & Toxicology ·Gopal Krishna, Lei Ma, (unknown), Allen Moton, Monika Martinho, Edward O’Mara	35
11	Lack of Pharmacokinetic Drug Interaction Between Oral Posaconazole and Caspofungin or Micafungin 2010 ·The Journal of Clinical Pharmacology ·Gopal Krishna, Donna Vickery, Lei Ma, Xin Yu, (unknown), (unknown), (unknown), Matthew M. Medlock	17
12	Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers 2009 ·Journal of Clinical Pharmacy and Therapeutics ·Allen Moton, Gopal Krishna, (unknown)	38
13	Effects of Oral Posaconazole on the Pharmacokinetics of Atazanavir Alone and With Ritonavir or With Efavirenz in Healthy Adult Volunteers 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Gopal Krishna, Allen Moton, Lei Ma, M. Martinho, Michael Seiberling, James F. McLeod	23
14	Tissue and Fluid Penetration of Garenoxacin in Surgical Patients 2007 ·Surgical Infections ·Charles E. Edmiston, Candace J. Krepel, Gary R. Seabrook, Jonathan B. Towne, Timothy L. Smith, Todd A. Loehrl, P. Ashley Wackym, Christopher P. Johnson, Mary F. Otterson, (unknown), Gopal Krishna	5
15	Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft‐versus‐Host Disease 2007 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Gopal Krishna, Monika Martinho, Pranatharthi Chandrasekar, Andrew J. Ullmann, Hernando Patino	151
16	Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men 2007 ·Current Medical Research and Opinion ·Gopal Krishna, Angela Sansone‐Parsons, Bhavna Kantesaria	42
17	The Effect of Omeprazole on the Bioavailability and Safety of Garenoxacin in Healthy Volunteers 2007 ·The Journal of Clinical Pharmacology ·Gopal Krishna, James C. Kisicki, Steven Olsen, Dennis M. Grasela, Zaiqi Wang	1
18	Effect of Oral Posaconazole on the Pharmacokinetics of Cyclosporine and Tacrolimus 2007 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Angela Sansone‐Parsons, Gopal Krishna, Monika Martinho, Bhavna Kantesaria, Steven P Gelone, Tim Mant	109
19	Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers 2007 ·Clinical Therapeutics ·Zaiqi Wang, Dennis M. Grasela, Gopal Krishna	4
20	A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma 2006 ·Journal of Pharmaceutical and Biomedical Analysis ·Jim X Shen, Gopal Krishna, Roger N. Hayes	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact